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Sirtuins have been the focus of intense scrutiny since the discovery of Sir2 as a yeast 
longevity factor. Functioning as either deacetylases or ADP ribosylases, Sirtuins are regu-
lated by the cofactor NAD and thus may serve as sensors of the metabolic state of the 
cell and organism. Here we examine the roles of Sirtuins in diverse eukaryotic species, 
with special emphasis on their links to aging and age-related diseases including cancer, 
diabetes, and neurodegenerative disorders.The study of aging in invertebrate model organisms has 
produced fundamental new observations about mecha-
nisms of eukaryotic aging. Among the genes that have 
been shown to regulate aging in different species are 
SIR2 and its functional orthologs that make up a fam-
ily of protein deacetylases termed Sirtuins. It has been 
known for four decades that histones can be acetylated 
(Roth et al., 2001), although the enzymes that acetylate 
and deacetylate lysine residues on histones and other 
proteins have only been discovered more recently. His-
tone and protein deacetylases fall into four classes with 
the yeast proteins Rpd3 (class I), Hda1 (class II), and Sir2 
(class III) serving as charter members of the three major 
classes (Blander and Guarente, 2004; Sengupta and 
Seto, 2004). Human HDAC11, the sole member of class 
IV, is conserved in mice and D. melanogaster but not C. 
elegans and yeast (Gao et al., 2002). Class III deacety-
lases, the Sirtuins, are unique in that they require NAD as 
a cofactor (Blander and Guarente, 2004; Denu, 2003). In 
a complicated two-step reaction, Sirtuins couple lysine 
deacetylation to NAD hydrolysis, yielding O-acetyl-ADP-
ribose and nicotinamide (Denu, 2003). As such, Sirtuin 
activity may be controlled by cellular [NAD]/[NADH] 
ratios and respond to changes in cellular metabolism 
(Lin et al., 2000, 2002, 2004).
Both class I and III deacetylases have been linked 
to aging (Bitterman et al., 2003), although most stud-
ies have focused on the class III Sirtuins. Increased Sir2 
activity has been reported to enhance yeast replicative 
life span (described below) (Kaeberlein et al., 1999), as 
well as the life span of C. elegans and D. melanogaster 
(Rogina and Helfand, 2004; Tissenbaum and Guarente, 
2001). In contrast, reduced Sir2 activity extends yeast 
chronological life span (described below) under nutri-
ent poor conditions or in combination with mutations in 
genes such as RAS2 and SCH9, which function in glu-
cose-responsive signal transduction pathways (Fabrizio 
et al., 2005). Numerous studies of Sirtuin function have 
been performed in mammalian cells, although it remains 
unknown whether Sirtuins directly regulate life span. In this study, we examine the role of Sir2 and other Sirtu-
ins in invertebrate aging. In addition, we discuss Sirtuin 
functions in mammals and how they may affect human 
longevity and age-related disease.
Sirtuins and Yeast Replicative Life Span
The asymmetrical division characteristic of the yeast 
S. cerevisiae is the basis for replicative life-span meas-
urements. Mother cells give rise by budding to smaller, 
easily distinguishable daughter cells. Micromanipula-
tion is used to remove successive daughters, which are 
counted as generations and tabulated (Mortimer and 
Johnston, 1959). Considerable effort has been directed 
toward identifying genes that regulate yeast replicative 
aging. Researchers have placed emphasis on mutations 
and interventions that lengthen yeast life span, reasoning 
that interventions reducing life span may not be directly 
linked to the aging process. To date, approximately 50 
mutations, mostly gene deletions, have been reported to 
result in increased replicative life span (Bitterman et al., 
2003; Kaeberlein et al., 2005b).
The first link between SIR2 and aging came from the 
finding that specific mutations in a component of the 
yeast SIR complex resulted in extension of replicative life 
span (Kennedy et al., 1995). At the time, the SIR complex 
(Sir2, Sir3, and Sir4) was known to repress transcrip-
tion of two yeast silent mating-type loci (which contain 
untranscribed copies of mating determination genes) 
and of genes placed near yeast telomeres (Rusche et 
al., 2003). Initially, it was speculated that SIR activity at 
telomeres may be regulating yeast aging, but followup 
analysis indicated that enhanced life span correlated 
with relocalization of the SIR complex to the nucleolus 
(Kennedy et al., 1997), the subnuclear location of ribos-
omal DNA (rDNA) genes and a major site of ribosome 
biogenesis.
Homologous recombination within rDNA repeats can 
lead to the formation of extrachromosomal rDNA cir-
cles (ERCs). Sir2 inhibits rDNA recombination and can 
also repress transcription of inserted genes that are Cell 126, July 28, 2006 ©2006 Elsevier Inc. 257
Figure 1. Models for Life-Span Extension 
by Enhanced Sir2 Function
Life-span extension by enhanced Sir2 func-
tion has been reported in three invertebrate 
models systems. In yeast, elevated Sir2 activ-
ity has been reported to extend replicative life 
span by inhibiting recombination in the rDNA 
repeats and therefore inhibiting the formation 
of extrachromosomal rDNA circles. Whether 
calorie restriction (CR) extends yeast replica-
tive life span by enhancing Sir2 function re-
mains a topic of debate (see text for discus-
sion). Further, the ability of two other yeast 
Sirtuins (Hst1 and Hst2) to compensate for 
Sir2 and inhibit rDNA recombination remains 
controversial. In D. melanogaster, enhanced 
dSir2 expression leads to long life span al-
though the longevity-enhancing effects of 
dSir2 have not been reported. CR is reported 
to enhance dSir2 activity. Finally, in C. elegans, elevated SIR-2.1 expression leads to an increase in life span that is dependent on DAF-16, a 
FOXO transcription factor that is regulated by insulin signaling. Life-span extension by CR is either partly abrogated or not affected by sir-2.1 
deletion, depending on the chosen method of CR (see text for discussion).transcribed by PolII (Rusche et al., 2003). Since ERCs 
contain a site of replication initiation but no centromere, 
they undergo replication during S phase but remain in 
the mother cell nucleus during mitosis. Accumulation of 
ERCs within a mother cell is one cause of yeast replica-
tive aging (Sinclair and Guarente, 1997). In the absence 
of SIR2, the rate of ERC formation is enhanced and cells 
are short lived (Kaeberlein et al., 1999). Reduced recom-
bination mediated by SIR2 overexpression or deletion of 
the FOB1 gene leads to lower ERC levels and results 
in extended yeast replicative life span (see Figure 1 for 
longevity extending roles of Sir2 orthologs) (Defossez 
et al., 1999; Kaeberlein et al., 1999). Fob1 has replica-
tion fork blocking activity and also promotes recombi-
nation within the rDNA (Kobayashi and Horiuchi, 1996). 
Although increased activity of Sir2 orthologs is associ-
ated with life-span extension in worms and flies (Rogina 
and Helfand, 2004; Tissenbaum and Guarente, 2001), 
there is no evidence of a link between ERCs and aging in 
any organism other than yeast.
Calorie Restriction and Yeast Replicative Aging
Calorie restriction (CR), defined as a reduction in organ-
ismal energy intake, has been shown to enhance longev-
ity of organisms ranging from yeast to mammals. Yeast 
is a valuable system in which to study calorie restric-
tion because nutrient-responsive pathways regulating 
cell growth are relatively well understood. CR in yeast 
can be induced by a reduction of glucose in the growth 
media or by mutations (such as the deletion of hexoki-
nase 2) that reduce the metabolism of glucose (Lin et al., 
2000). The role of Sir2 in the calorie restriction response 
is controversial (Guarente, 2005; Kennedy et al., 2005). 
Importantly, it remains undisputed that increased Sir2 
activity leads to replicative life-span extension; only the 
proposed link between Sir2 and CR has been called into 
question.
Initially, it was reported that SIR2 was required for 
life-span extension by calorie restriction in yeast. This 
conclusion was based on an also undisputed finding 258 Cell 126, July 28, 2006 ©2006 Elsevier Inc.that short-lived strains lacking SIR2 did not exhibit life-
span extension under CR conditions. In the absence of 
SIR2, ERCs accumulate. Thus, the finding that CR fails 
to increase life span in a strain lacking SIR2 can be inter-
preted in one of two ways. Either CR directly leads to a 
reduction in ERC levels by enhancing Sir2 activity (Lin 
et al., 2000) or yeast strains lacking SIR2, which have 
an approximate 50% reduction in mean replicative life-
span potential, prematurely succumb to elevated ERCs 
and do not live long enough to respond to CR.
It has been reported that CR causes robust life-span 
extension in the absence of SIR2 as long as ERCs are 
kept at low levels by deletion of FOB1 (Kaeberlein et al., 
2004), a finding that has since been supported by another 
group (Lamming et al., 2005) but not supported in an 
earlier study using a different yeast strain background 
(Lin et al., 2002). This was interpreted by Kaeberlein et 
al. to indicate that SIR2 is required not as a direct effec-
tor of calorie restriction but indirectly to maintain low 
ERC levels and thus enable the cells to live long enough 
to respond to CR (Kaeberlein et al., 2004). To reiterate, 
there is general agreement that CR can extend replica-
tive life span in a strain lacking both SIR2 and FOB1 but 
not in a strain that lacks only SIR2. However, followup 
experiments and interpretations thereof have led differ-
ent groups to different conclusions regarding the impor-
tance of Sir2 for the CR response (see below). CR imple-
mented by a reduction in amino acids is also reported 
to extend yeast replicative life span (Jiang et al., 2002). 
Extension in this case is independent of SIR2.
One of the authors (B.K.K.) is at the center of the 
dispute regarding the importance of Sir2 in the CR 
response. However, we will present both views to the 
best of our ability. The debate currently rests on the 
extent of glucose limitation used to implement the CR 
response. Guarente, Lin, Sinclair, and colleagues believe 
that reducing the glucose concentration from 2% to 
0.5% (4× reduction) is ideal since it has a minimal effect 
on yeast growth rate and may be more physiologically 
similar to levels of calorie restriction employed in other 
model organisms (Lamming et al., 2006; Lin and Guar-
ente, 2006). They propose that CR mediated by a reduc-
tion in glucose concentration to 0.05% may be SIR2 
independent and mediated through a different mecha-
nism. Kaeberlein, Kennedy, and colleagues have largely, 
but not exclusively, used 0.05% glucose (40× reduction) 
because it maximizes life-span extension (Kaeberlein et 
al., 2004, 2005a, 2006b), permitting easier interpretation 
of epistasis analysis (Clancy et al., 2002). They support 
a model whereby life-span extension by CR is Sirtuin 
independent and not fundamentally different at either 
level of glucose limitation (Kaeberlein et al., 2005a, 
2006a, 2006b). At either 0.5% or 0.05% glucose, CR 
extends life span in a manner dependent on the nutri-
ent-responsive kinases, TOR, PKA, and SCH9 (the Akt 
ortholog) (see brief discussion below) (Fabrizio et al., 
2001; Kaeberlein et al., 2005d; Lin et al., 2000). These 
nutrient-responsive kinases control numerous down-
stream responses including ribosome biogenesis and 
cell growth, stress responses, and autophagy. Which of 
these are important for life-span extension remains to 
be determined. Although deletion of SCH9 does reduce 
recombination in the rDNA (Prusty and Keil, 2004), it is 
clear from a variety of epistasis studies that this pheno-
type does not explain replicative life-span extension. For 
example, double mutants lacking both SCH9 and FOB1 
survive much longer than mutants lacking only FOB1, 
which already have extremely low levels of ERCs (Kae-
berlein et al., 2005d).
Life-span extension by CR at 0.5% or 0.05% glucose 
can occur in the absence of SIR2, as long as FOB1 is 
also deleted (Kaeberlein et al., 2004; Lamming et al., 
2005). Two findings led Lamming et al. to propose that 
other Sirtuins were, together with Sir2, acting in a redun-
dant fashion to mediate the calorie restriction response 
under these conditions (Lamming et al., 2005). First, 
nicotinamide, a known inhibitor of Sirtuin enzymatic 
activity, can block at least some of the life-span exten-
sion by CR even in the absence of Sir2 (Kaeberlein et 
al., 2005a; Lamming et al., 2005). Second, a screen for 
genes that when overexpressed led to enhanced rDNA 
silencing resulted in the identification of HST2, another 
Sirtuin (Lamming et al., 2005). Although Hst2 is normally 
cytoplasmic (Perrod et al., 2001), under CR conditions it 
is reported to relocalize to the nucleus (Lamming et al., 
2005). Further, Lamming et al. report that, analogously 
to strains lacking SIR2, yeast lacking only HST2 exhibit 
elevated rDNA recombination and a short life span. The 
finding regarding rDNA recombination contrasts with a 
previous report by Gasser and colleagues, who found 
that a yeast strain lacking HST2 exhibits reduced rDNA 
recombination (Perrod et al., 2001).
At 0.5% glucose, Lamming et al. report that CR fails to 
extend life span in a strain lacking both SIR2 and HST2, 
leading to the conclusion that CR extends life span by 
reducing rDNA recombination and ERC formation in a 
SIR2- and HST2-dependent fashion (Lamming et al., 
2005). Hst1, another Sirtuin, may also compensate for Sir2 in some strains. Another group has found using 
the same genetic background that CR extends life span 
in yeast strains that lack SIR2, HST2, and FOB1 or in 
yeast that also lack HST1 (Kaeberlein et al., 2006b). 
The reason(s) for these disparate findings are being 
actively debated (Kaeberlein et al., 2006b; Lamming et 
al., 2006).
Finally, longevity extension by CR has been linked to 
cellular respiration. Work from Guarente, Sinclair, and 
colleagues has led to the model that CR leads to elevated 
NAD levels (Lin et al., 2002), reduced NADH levels (Lin 
et al., 2004), and/or reduced nicotinamide levels (Ander-
son et al., 2003; Bitterman et al., 2002), which in turn 
lead to Sir2 activation. Reducing glucose levels in yeast 
enhances the respiratory rate of the facultative anaer-
obe, and it has been proposed that this enhanced rate 
of respiration leads to increased [NAD]/[NADH] ratios. 
Furthermore, CR fails to increase replicative life span of 
respiratory-deficient yeast (Lin et al., 2002), although 
this finding has also been disputed (Kaeberlein et al., 
2005a). Whether differential levels of glucose depriva-
tion underlie the disparate findings of these studies also 
continues to be debated (Kaeberlein et al., 2006a; Lin 
and Guarente, 2006).
Sir2 and Yeast Chronological Life Span
The chronological life-span models aging in the natural 
environment because it is a measure of the survival of 
yeast populations in a nondividing state (Longo et al., 
1997). The median chronological life span of S. cerevi-
siae wild-type DBY746 or SP1 yeast grown in glucose 
medium (SDC) is 6 to 7 days. Under these conditions 
wild-type DBY746 cells have excess ethanol available 
for energy production and maintain high metabolic rates 
for the majority of the life span. A form of severe calorie 
restriction, achieved by switching cells from ethanol/glu-
cose-containing medium to water between days 1 and 
5, causes a decrease in metabolic rates and extends 
survival by 2- to 3-fold (Fabrizio et al., 2004a; Longo et 
al., 1997).
Yeast strains with reduced activity of Ras2 or any of 
the nutrient-responsive kinases Sch9, PKA, and TOR 
have extended chronological life span (Fabrizio et al., 
2001, 2003, 2004b; Powers et al., 2006). Importantly, 
Sch9 is a functional homolog of Akt/PKB, a component 
of the conserved pro-aging pathways of worms, flies, 
and mice (Longo and Finch, 2003).
In contrast to the role of ERCs in yeast replicative 
aging, superoxide appears to play a central role in S. 
cerevisiae chronological aging and death. In fact, the 
superoxide-sensitive 4Fe-4S cluster enzyme aconi-
tase is inactivated preceding the high mortality phase 
(Fabrizio et al., 2001), and overexpression of the super-
oxide dismutases SOD1 or SOD2 extends chronologi-
cal life span (Fabrizio et al., 2003). Spontaneous DNA 
mutation frequency also increases with chronological 
age, although its role in aging and death remains poorly 
understood (Fabrizio et al., 2004a, 2005).Cell 126, July 28, 2006 ©2006 Elsevier Inc. 259
Figure 2. Models for Life-Span Extension 
by Reduced Sir2 Function
In the yeast chronological life-span assay, deletion 
of SIR2 has been shown to enhance survival in a 
postmitotic state either in low nutrient conditions 
or when combined with mutations in nutrient-re-
sponsive kinases such as Ras, Sch9 (Akt), and 
TOR. Strains lacking Sir2 show elevated stress 
resistance and enhanced alcohol dehydrogenase 
activity under these conditions, although the 
mechanisms by which Sir2 regulates these proc-
esses remain largely unknown. In mammals, the 
longevity effects of Sirt1 have not been reported. 
However, Sirt1 is reported to have a number of 
functions that may regulate longevity. The path-
way in green is reported to occur specifically in 
pancreatic β cells, and the pathway in purple is 
reported specifically for adipocytes.The role of Sir2 in the chronological survival of non-
dividing yeast cells has only recently been examined 
(Fabrizio et al., 2005) and appears to be quite different 
from its role in the yeast replicative life span. Deletion 
of SIR2 increases stress resistance but has no effect 
on the chronological life span of wild-type yeast grown 
and maintained in medium. However, deletion of SIR2 
extends further the chronological life span caused by 
severe CR (incubation in water) (Fabrizio et al., 2005) or 
caused by mutations that decrease PKA or Sch9 activity 
(see Figure 2 for possible longevity-limiting roles of Sir2 
orthologs). Furthermore, the overexpression of SIR2 has 
no effect on the chronological life span of wild-type cells 
and reduces the life span of cells lacking Sch9 activ-
ity (Fabrizio et al., 2005). Other Sirtuins have not been 
examined in this aging assay. Evidence exists for two 
possible mechanisms by which deletion of SIR2 results 
in life-span extension when coupled with reduced nutri-
ent-responsive kinase activity or CR. First, deletion of 
SIR2 in combination with reduced PKA or Sch9 activity 
was found to increase the expression of many stress-
resistance and sporulation genes and to decrease the 
rate of DNA mutations that accumulate with age in post-
mitotic conditions (Fabrizio et al., 2005). This contrasts 
with the role of Sir2 in mitotically active cells, where it 
promotes genome stability by repressing recombina-
tion (Blander and Guarente, 2004). Second, Fabrizio et 
al. report that cells lacking SIR2 have elevated levels of 
the alcohol dehydrogenase Adh2 (Fabrizio et al., 2005). 
Mitotically active yeast cells primarily generate energy 
through fermentation, which leads to the production of 
ethanol. As fermentable carbon sources become scarce 
and ethanol accumulates, yeast undergo a metabolic 
shift and begin to utilize ethanol as an energy source, 
only entering stationary phase after ethanol levels are 
largely depleted. In the absence of Sir2, increased alco-
hol dehydrogenase activity leads to more rapid ethanol 
degradation and entry into a more stable postmitotic 
state. The mechanism by which Sir2 negatively regulates 
Adh2 levels as cells enter a postmitotic state is yet to be 
determined. Increased ethanol uptake may represent an 
attempt by cells lacking SIR2 to prepare for long periods 
of starvation.260 Cell 126, July 28, 2006 ©2006 Elsevier Inc.In summary, although the deletion of SIR2 decreases 
and its overexpression increases the yeast replicative life 
span, changing Sir2 levels does not significantly affect 
the chronological life span. However, when combined 
with severe CR- or life-span-extending mutations that 
reduce the activity of the Ras and Sch9 pathways, muta-
tions in SIR2 do extend the chronological life span and 
Sir2 overexpression limits life-span extension in mutants 
lacking SCH9. Loss of SIR2 may promote entry into a 
state that protects cells against aging during starva-
tion. These results suggest that Sir2 plays very different 
roles in the regulation of replicative and chronological 
life span.
One Model Organism, Two Measures of Aging?
The replicative life span of yeast is in many respects 
analogous to the replicative life span of mammalian 
fibroblasts and lymphocytes, which undergo a limited 
number of population doublings in culture. Thus, repli-
cative aging in yeast may be a model to study replicative 
aging in mitotically active mammalian cells. By contrast, 
chronological aging in yeast may serve to model aging in 
postmitotic mammalian cells (e.g., neurons) and organ-
isms. To what extent do similar pathways regulate the 
mechanisms that lead to replicative and chronological 
aging in the same model organism?
Whereas earlier studies showed similarities but also 
major differences between the regulation of replicative 
and chronological life span, more recent studies are 
beginning to suggest that there may be only one form of 
“aging” in S. cerevisiae with two ways to measure it. A 
large-scale search for mutants with an extended replica-
tive life span led to the identification of deletion mutants 
in sch9 and tor1, also implicated in chronological life-
span extension (Fabrizio et al., 2001; Kaeberlein et al., 
2005d; Powers et al., 2006). Thus, nutrient-responsive 
kinases control aging of both mitotic and postmitotic 
cells. Whether the effectors that regulate each type of 
aging downstream of these kinases are the same remains 
to be determined. Notably, reduced activity of orthologs 
of these kinases and/or of the pathways in which they 
function lead to life-span extension in worms, flies, 
and mammals (Kenyon, 2005; Longo and Finch, 2003). 
We suspect that inhibition of these nutrient-respon-
sive kinases leads to life-span extension in mammals 
because it provides distinct, beneficial effects in both 
mitotic and postmitotic populations of cells. Support for 
this comes from yeast replicative and chronological life-
span studies but also from longevity experiments in C. 
elegans, where it was shown that reduced insulin/IGF-1 
signaling can slow a variety of age-related phenotypes 
in distinct tissues (Garigan et al., 2002). Similar effects 
have been observed for CR in mice.
For yeast replicative life span, double mutants lacking 
FOB1 and either SCH9 or TOR1 are extremely long lived, 
suggesting that the accumulation of ERCs caused by 
Fob1 may, to a degree, mask the effect of loss of SCH9 
or TOR1 on replicative life-span extension. Thus, ERCs 
may be responsible for one discrepancy between the 
effect of Sir2 on replicative and chronological life span. 
If Sir2 is absent, ERCs accumulate early and either kill 
the cell or prevent its division. If Sir2 is overexpressed, 
ERC levels are decreased and replicative life span is 
enhanced. ERCs may then be viewed as an agent that 
hastens death specifically in yeast and obscures other 
more universal aging processes. However, deletion of 
SIR2 does not extend the replicative life span of strains 
lacking SCH9 or TOR1 even in the absence of FOB1, so 
there must be other underlying differences as well.
The force of natural selection against the appear-
ance of “defects” is very high in young organisms, but 
it declines at advanced ages. Yeast mother cells do not 
need to produce 25 daughters to ensure colony survival 
or even a maximal colony growth rate, and, therefore, 
deleterious events that are specific to old mother cells 
(such as ERC formation or reduced growth rates) may 
not be subject to counterselection. Thus, ERCs appear 
to be a major cause of aging only in yeast subjected to 
conditions not normally encountered in natural environ-
ments. In contrast, other mechanisms of aging may be 
conserved, and evidence not only from yeast chronolog-
ical and replicative aging studies, but also from higher 
eukaryotes, is beginning to show that the Sch9 (Akt), 
Ras, and Tor may be universal regulators of these mech-
anisms. Sir2 is clearly important for life-span regulation 
but it may play either a pro- or an anti-aging role in differ-
ent organisms depending on the availability of nutrients 
and on the activity of glucose signaling pathways.
Sir2 and Aging in Other Invertebrates
Two other model organisms where aging has been stud-
ied extensively are C. elegans and D. melanogaster. In 
this section we summarize findings regarding the role 
of Sir2 orthologs in aging in these invertebrates. Other 
Sirtuins are present in both organisms, but their roles in 
aging have not been ascertained. In C. elegans, increased 
dosage of the SIR2 ortholog, sir-2.1, increases the mean 
life span by up to 50% (Figure 1) (Tissenbaum and Guar-
ente, 2001), and this extension requires the FOXO tran-
scription factor DAF-16, which is known to be regulated 
by the insulin/IGF-1 pathway. Rather than acting directly in the insulin/IGF-1 signaling pathway, two recent stud-
ies suggest that SIR-2.1 may act in a parallel pathway 
that converges at the point of DAF-16 regulation (Wang 
et al., 2006) (Berdichevsky et al., 2006). In both studies, 
both C. elegans 14-3-3 proteins were identified as SIR-
2.1 interactors, an intriguing finding because mammalian 
14-3-3 proteins are known to bind FOXO transcription 
factors and sequester them in the cytoplasm (Brunet et 
al., 1999). Although life-span extension by SIR-2.1 over-
expression can be blocked by reducing expression of 
14-3-3 proteins, this is not the case for mutations that 
disrupt the insulin pathway (Wang et al., 2006) (Berdi-
chevsky et al., 2006). For instance, the long life span 
of a daf-2 mutant is not affected by a reduction in 14-
3-3. In fact, deletion of sir-2.1 does not reduce the life 
span of a daf-2 mutant and instead appears to slightly 
increase it, consistent with the longer chronological life 
span observed for yeast lacking both SIR2 and the Akt 
homolog SCH9 (Berdichevsky et al., 2006; Fabrizio et 
al., 2005; Wang and Tissenbaum, 2006).
Berdichevsky et al. propose that SIR-2.1 is part of a 
stress-response pathway that regulates DAF-16 activity 
in a manner dependent on 14-3-3 proteins (Berdichevsky 
et al., 2006). Consistent with this idea, a null mutant of 
C. elegans sir-2.1 not only has a slightly shorter life span 
but exhibits sensitivity to a variety of stresses includ-
ing hydrogen peroxide, UV irradiation, and heat shock 
(Wang and Tissenbaum, 2006). These results only par-
tially agree with those observed for nondividing yeast. 
In fact, in yeast lacking SIR2 the chronological life span 
is either normal or slightly shorter, DNA mutations are 
more frequent, but sensitivity to heat shock and oxida-
tive stress is reduced (Fabrizio et al., 2005). SIR-2.1 is 
also reported to be important for silencing of transgenes 
inserted into genomic repeat elements, perhaps in a 
manner analogous to Sir2-dependent silencing in yeast 
(Jedrusik and Schulze, 2003). Whether this activity is 
important for longevity regulation remains to be deter-
mined.
Different assays have been proposed for calorie 
restriction in C. elegans, including use of eat-2 mutants 
that eat less than wild-type worms, growth in axenic 
media that lacks a bacterial food source, and reduced 
exposure to food source or dietary restriction (Walker 
et al., 2005). The dependence of sir-2.1 has been deter-
mined for eat-2 mutants and dietary restriction, with 
somewhat different results. Life-span extension by eat-
2 mutants is partially suppressed by deletion of sir-2.1 
(Wang and Tissenbaum, 2006). In contrast, life-span 
extension by dietary restriction is not affected by sir-2.1 
deletion (M. Kaeberlein, personal communication). Also, 
whereas life-span extension by sir-2.1 overexpression 
is daf-16 dependent (Tissenbaum and Guarente, 2001), 
life-span extension by CR is not (Lakowski and Hekimi, 
1998).
Small molecule activators and inhibitors of Sirtuins 
have been reported. Resveratrol has been proposed as a 
small molecule agonist of yeast Sir2 and of its orthologs Cell 126, July 28, 2006 ©2006 Elsevier Inc. 261
in worms, flies, and mammals and has been studied in 
the context of longevity (Wood et al., 2004). Resveratrol 
was identified in a screen for Sirtuin activators using a 
nonbiological substrate suitable for high-throughput flu-
orescent analysis (Howitz et al., 2003). However, other 
groups have shown that the stimulatory effects of res-
veratrol on Sirtuin enzyme activation are specific to this 
nonnative substrate (Borra et al., 2005; Kaeberlein et al., 
2005c). No enhancement of enzyme activity was seen 
with native acetylated peptides. One possibility is that 
resveratrol only stimulates Sirtuin activity toward spe-
cific substrates in vivo. Alternatively, the effects of resev-
eratrol may be largely Sirtuin independent, an assertion 
consistent with observations that the polyphenol com-
pound has a plethora of other activities. Reports conflict 
as to whether resveratrol extends yeast life span (Howitz 
et al., 2003; Kaeberlein et al., 2005c).
In C. elegans, sir-2.1-dependent life-span extension 
has been observed for resveratrol (Wood et al., 2004). 
A recent report however has suggested that, rather 
than enhance SIR-2.1 activity in worms, resveratrol may 
extend life span by antagonizing it (Viswanathan et al., 
2005). Also, unlike sir-2.1 overexpression, resveratrol 
extends life span in a daf-16-independent manner. The 
key target for life-span extension due to resveretrol treat-
ment appears to be abu-11, an endoplasmic reticulum 
(ER) stress-family gene. Either addition of resveratrol 
or, curiously, sir-2.1 deletion leads to enhanced abu-11 
expression, which is in turn required for life-span exten-
sion. The authors put forth a model to explain these 
seemingly paradoxical findings by proposing that (1) 
resveratrol may bind to SIR-2.1 and change its specifi-
city toward substrates such that deacetylation of some 
substrates may be enhanced whereas deacetylation of 
other substrates is impeded and (2) SIR-2.1 has multiple 
functions that impinge on longevity regulation with the 
net effect being that overexpression extends life span. 
Thus, as with Sir2 in yeast, SIR-2.1 in worms may have 
some activities that promote longevity and others that 
limit it. Perhaps the most interesting finding from this 
study is that overexpression of abu-11 extends worm life 
span, implicating ER stress as a limiting factor in worm 
longevity.
In flies, the Sir2 ortholog dSir2 has been reported to 
extend life span as well (Rogina and Helfand, 2004). In 
addition, life-span extension by CR is blocked in strains 
lacking dSir2 (Figure 1). These findings suggest that 
CR works through a Sir2-dependent mechanism in 
this organism. Mutant flies with reduced Rpd3 (class I 
deacetylase) activity exhibit extended life span that is 
dependent on dSir2, indicating that the two deacety-
lases are in a single pathway regulating aging with Rpd3 
upstream (Rogina and Helfand, 2004; Rogina et al., 
2002). It has not been determined whether Rpd3 regu-
lates [NAD]/[NADH] ratios in flies. Life-span extension 
by resveratrol is also reported to be dSir2 dependent 
(Wood et al., 2004). Little is known about dSir2 func-
tion in flies, especially regarding aging-specific func-262 Cell 126, July 28, 2006 ©2006 Elsevier Inc.tions. This deacetylase has been reported to be involved 
in transcriptional repression (Newman et al., 2002), at 
least in part through interactions with Hairy, a transcrip-
tion factor involved in developmental regulation (Rosen-
berg and Parkhurst, 2002). Whether dSir2 regulates the 
insulin pathway in flies remains to be determined.
In summary, overexpression of Sir2 orthologs 
increases fly and worm life span, and the links between 
Sir2 orthologs and calorie restriction appear inconsist-
ent between organisms and remain to be fully under-
stood. It seems paradoxical that the impetus for exam-
ining the life span of worms and flies overexpressing 
their Sir2 orthologs derived from yeast replicative aging 
studies, given that the proposed role of Sir2 in longev-
ity regulation, reducing ERC production, seems not to 
be conserved. We offer three possible explanations to 
resolve this paradox. First, Sir2 in yeast may have other 
functions aside from reduced ERC production that pro-
mote replicative longevity, and this activity may be con-
served. Second, worm and fly Sir2 orthologs may extend 
life span by repressing recombination at other chromo-
somal regions that are more sensitive (e.g., repetitive 
DNA) and that do not exist in yeast or influence yeast 
life span. It is hard to interpret this model in the context 
of C. elegans where daf-16 is required for the longevity 
effects of sir-2.1 overexpression. Finally, Sir2 orthologs 
may have evolved to couple metabolic signals to specific 
longevity-enhancing functions in different organisms, a 
model promoted by Guarente and colleagues (Guarente 
and Picard, 2005). How this last model would fit with 
evolutionary theories of aging remains to be resolved. 
We will have to await further experiments in each of 
these organisms to begin to differentiate between these 
models, or devise a different one. Further adding to the 
incongruity is the finding that loss of SIR2 in some con-
texts enhances yeast chronological life span and that its 
overexpression does not affect or reduces chronological 
longevity (Fabrizio et al., 2005).
Sirtuins in Mammals
The aging phenotype of mice overexpressing Sirt1, and 
the effects of CR on longevity in a mouse lacking Sirt1, 
has not yet been determined. Although a majority of Sirt1 
null animals succumb to developmental defects during 
early postnatal development (Cheng et al., 2003; McBur-
ney et al., 2003), the remaining mice survive and have 
phenotypes resembling mice overexpressing IGFBP-1 
or lacking IGF-I (Longo and Finch, 2003) (see below). 
In Sirt1-deficient adult survivors, Chen et al. report 
that calorie restriction fails to induce increased physi-
cal activity (Chen et al., 2005a), a common CR-induced 
behavioral change in wild-type mice. However, physi-
ologic changes similar to those caused by CR, such as 
reduced blood glucose, triglycerides, and insulin levels, 
occur normally in these animals. Although these latter 
phenotypes might be expected to extend longevity, the 
effect of Sirt1 deficiency alone or in combination with CR 
remains to be established. Nevertheless, a number of 
studies have reported in mammals intriguing functions 
of Sirtuins that may pertain to aging. In the following 
sections, we outline some of these findings, focusing on 
results that relate to aging and age-related disease.
Sir2/Sirt1, Genomic Instability, and Oncogenesis
Initial links between Sir2 function and the response to 
DNA damage came from studies in S. cerevisiae. In pro-
liferating yeast, several reports indicate that Sir2 pro-
tects against DNA damage by inducing nonhomologous 
end joining and homologous recombination pathways, a 
function which appears to depend on the derepression 
of silent mating-type genes (Fabrizio et al., 2005; Lee 
et al., 1999). Sir2 also mediates the asymmetric inherit-
ance of oxidatively damaged proteins during cell division 
(Aguilaniu et al., 2003). Mother cells have a limited life 
span, but the colonies they produce will continue prolif-
erating as long as sufficient nutrients are available. This 
asymmetric inheritance restricts damaged proteins to 
the mother cell, likely ensuring the generation of rela-
tively damage-free daughters and continued colony pro-
liferation. In contrast, Sir2 appears to promote chrono-
logical age-dependent genomic instability in long-lived 
mutants. S. cerevisiae cells accumulate spontaneous 
DNA mutations with chronological age, and this accumu-
lation is drastically reduced in strains lacking both SCH9 
and SIR2 (Fabrizio et al., 2005). Although this effect of 
Sir2 deficiency appears to be independent of the dere-
pression of silent mating-type genes, the mechanisms 
by which Sir2 promotes age-dependent genomic insta-
bility are not known.
In mammals, considerable evidence exists to suggest 
that the tumor suppressor p53 is a target for deacetyla-
tion by Sirt1 (Cheng et al., 2003). Under normal cellular 
conditions for proliferation, p53, a transcriptional acti-
vator, is highly unstable (Gu et al., 2004). p53 stabiliza-
tion occurs as part of a checkpoint response to cellular 
stress (including DNA damage) and results in prolifera-
tive arrest, followed by either reentry into the cell cycle, 
senescence, or apoptosis. Acetylation of p53 leads to 
enhanced transcriptional activation as part of the check-
point response. By deacetylating p53, Sirt1 may turn off 
p53 after recovery from stress to allow cell proliferation to 
resume. Although it has been shown that increased Sirt1 
activity leads to hypoacetylation of p53 and repression 
of p53 target genes (Luo et al., 2001; Vaziri et al., 2001), 
the cellular consequences of this remain in question. 
Whereas Sirt1 activity was originally reported to inhibit 
apoptosis through deacetylation of p53 (Langley et al., 
2002; Luo et al., 2001), more recent reports suggest that 
although Sirt1 can deacetylate p53 there is little effect on 
p53-mediated biological outcomes (Kamel et al., 2006; 
Solomon et al., 2006). Other stress response-related 
proteins linked to Sirt1 are Ku70 and NF-κB (see below) 
(Cohen et al., 2004; Yeung et al., 2004). Ku70, a DNA 
repair factor, is reported to be a target for deacetyla-
tion by Sirt1, which is another mechanism by which Sirt1 
might inhibit cell death (Cohen et al., 2004).Expanding on links between Sir.2-1 and daf-16 in 
worms, several studies have tested the hypothesis that 
Sirt1 can regulate mammalian FOXO transcription fac-
tors through direct binding and/or deacetylation. Sirt1 
deacetylation can either lead to activation or repres-
sion of FOXO-dependent transcription depending on 
the context (Greer and Brunet, 2005). Current thinking 
is that deacetylation of FOXO factors by Sirt1 may lead 
to activation of a set of stress-resistant factors, tipping 
the balance toward stress resistance and away from 
apoptosis (Brunet et al., 2004). There also exists an intri-
cate interplay between FOXOs, Sirt1, and p53, with each 
being able to regulate the other two in at least some 
cellular contexts (Greer and Brunet, 2005). Because all 
three of these proteins have been linked to aging, it is 
imperative that future studies delineate these complex 
interactions.
Sirt1 function has also been examined in the context 
of cellular senescence in cell culture. Chua et al. report 
that mouse embryo fibroblasts lacking Sirt1 are resist-
ant to senescence in the presence of sublethal, chronic 
oxidative stress (Chua et al., 2005). Interestingly, onco-
gene-induced senescence occurs normally in these 
cells. Consistent with this result, nicotinamide, a sirtuin 
inhibitor, has been reported in another study to extend 
the replicative life span of primary human fibroblasts (Lim 
et al., 2006), although no experiments were presented 
that directly link the actions of nicotinamide to Sirt1 or 
other Sirtuins in this context. Preliminary studies exam-
ining links between Sirt1 function and cancer suggest 
that it is enhanced Sirt1 activity that may be oncogenic 
(Figure 3). For instance, treatment of human breast and 
lung cancer cells with Sirtinol, another Sirt1 inhibitor, 
has been found to induce a senescent-like growth arrest 
(Ota et al., 2006). Related findings were reported by Ford 
et al. (Ford et al., 2005), who employed RNAi to silence 
expression of Sirt1. In this study, enforced reduction of 
Sirt1 led to growth arrest and/or apoptosis in human 
epithelial cancer lines but not primary epithelial cells.
Inhibitors of class I and class II histone deacetylases 
are under clinical trials as chemotherapeutic agents. 
The antitumor effects of these inhibitors likely stem from 
their ability to reactivate transcription of tumor sup-
pressor genes in combination with DNA-demethylating 
Figure 3. Sirt1, Aging, and Age-Related Disease
Although preliminary, Sirt1 is postulated to protect against neurode-
generation and diabetes but to promote tumorigenesis. However, its 
role in disease progression and aging in mammals remains to be fully 
determined. Future studies at the organismal level will be needed to 
address the relationships between Sirt1, aging, and age-related dis-
ease and will likely provide mechanistic insights into the modes of 
action of this important protein deacetylase.Cell 126, July 28, 2006 ©2006 Elsevier Inc. 263
agents. A similar role has recently been proposed for 
the Sirt1 inhibitors, which were found to promote the 
reactivation of tumor suppressor gene transcription 
in human breast and colon cancer lines (Pruitt et al., 
2006). In this case, re-expression could be achieved 
in the absence of inhibitors of DNA methylation even 
though the promoters in question remained highly 
methylated. Although there is no general agreement 
concerning the mechanisms by which Sirt1 might pro-
mote oncogenesis, these studies collectively point to 
the need for further investigation and the potential role 
of Sirtuin inhibitors in cancer treatment. These results 
may be consistent with the effect of SIR2 deletion 
mutations in increasing resistance to oxidative dam-
age, reducing DNA damage, and extending the yeast 
chronological life span in combination with mutations 
in nutrient-responsive kinases (Fabrizio et al., 2005). 
Thus, both yeast Sir2 and mammalian Sirt1 can pro-
mote DNA damage or oncogenesis, although they also 
play important roles in protecting against damage dur-
ing cell growth and organismal development.
Less closely related to the other Sirtuins, the primary 
activity of Sirt6 is ADP-ribosylation rather than deacetyla-
tion (Liszt et al., 2005). A recent report finds that mice 
lacking Sirt6 exhibit enhanced genome instability lead-
ing to a wide range of chromosomal anomalies as well 
as phenotypes resembling premature aging, including 
cachexia, kyphosis, and osteopenia (Mostoslavsky et 
al., 2006). Many other mutations leading to progeria in 
mammals are associated with genome instability. Mos-
toslavsky et al. find that mice lacking Sirt6 have a range 
of sensitivities to DNA-damaging agents including MMS 
and ionizing radiation that are consistent with defects 
in base excision repair (Mostoslavsky et al., 2006). The 
exact role of Sirt6 in this repair process remains to be 
determined.
Sirtuins and Mammalian Metabolism
Decreased insulin/IGF-I signaling is intimately linked 
to enhanced longevity in worms, flies, and mice 
(Longo and Finch, 2003). Further, deletion of the yeast 
orthologs of Akt and Ras, which function downstream 
of mammalian insulin/IGF-I, results in extended rep-
licative and chronological life span in yeast (Fabrizio 
et al., 2001, 2003, 2004b; Lin et al., 2000). Because 
insulin signaling links extracellular glucose levels to 
cell metabolism, and increased life span in worms 
overexpressing sir-2.1 is dependent on daf-16, con-
siderable effort has been devoted to uncovering the 
connections between Sirt1 function and metabolism 
in mammals. To date, the results of these studies have 
not generated a clear picture of the role of Sirt1 in 
these processes.
Two studies have examined the function of Sirt1 in 
the release of insulin by pancreatic β cells. Bordone et 
al. reported that an siRNA-enforced reduction of Sirt1 
expression in β cell lines leads to an increase in the 
expression of uncoupling protein 2 (UCP2) and a reduc-264 Cell 126, July 28, 2006 ©2006 Elsevier Inc.tion in insulin secretion (Bordone et al., 2006). This find-
ing may phenocopy food deprivation, which is known 
to induce UCP2 expression and reduce insulin secre-
tion. In a second study, Sirt1 expression was elevated 
specifically in the mouse pancreas, leading to reduced 
UCP2 expression and enhanced insulin secretion dur-
ing glucose stimulation (Moynihan et al., 2005). Sirt1 
also induces gluconeogenic genes and hepatic glucose 
output through the transcriptional coactivator PGC-1 α 
(Rodgers et al., 2005). At least with regard to β cell func-
tion, reduced Sirt1 may mimic rather than impede the 
effects of either CR or low-plasma IGF-I, in agreement 
with the other phenotypes described below for Sirt1 null 
mice, including small body size and increased levels of 
IGFBP-1 (Figure 2).
Sirtuins also have functions in adipose tissue. For 
instance, Picard et al. show that Sirt1 promotes fat 
mobilization in mammalian adipocytes by repressing 
PPARγ (Picard et al., 2004), and reduced fat content 
has been linked to extended longevity (Bluher et al., 
2003). However, it is storage and not the mobilization 
of fat that has been consistently associated with lon-
gevity extension in worms, flies, and mice, apparently 
as part of a program aimed at surviving long periods 
of starvation (Longo and Finch, 2003). Notably Sirt3, 
a mitochondrial Sirtuin, is expressed largely in brown 
fat, suggesting a role for this deacetylase in adaptive 
thermogenesis (Shi et al., 2005). Links between aging 
and Sirt3 have yet to be reported.
Are the metabolic consequences of altering Sirt1 lev-
els pro- or anti-aging (or both)? Elevated Sirt1 expres-
sion may extend life span by decreasing fat storage. 
On the other hand, reduced Sirt1 levels cause changes 
analogous to those observed in the long-lived IGF-
I-deficient mice (McBurney et al., 2003). The role for 
Sirt1 in reducing the expression of the IGF binding pro-
tein, IGFBP-1, in increasing hepatic glucose output, in 
increasing pancreatic insulin secretion, in mobilizing 
fat, and in preventing a dwarf phenotype raises the pos-
sibility that Sirt1 may play both a pro- and anti-aging 
role in mammals as has been shown in S. cerevisiae, 
C. elegans, and mammalian cells (Fabrizio et al., 2005; 
Kaeberlein et al., 1999).
It will be important to determine whether the role of 
Sirt1 in decreasing IGFBP-1 and fat storage and increas-
ing hepatic glucose output and pancreatic insulin secre-
tion is evidence for entry into a pro-aging mode and/or 
whether Sirt1 regulates systems that may promote phys-
ical activity during periods of starvation for the purpose 
of finding food or avoiding predation. In fact, the increase 
in activity of mice during CR requires Sirt1 (Chen et al., 
2005a). One possibility is that, during CR, mammalian 
Sirt1 plays a role in inhibiting entry into a nonreproduc-
tive and reduced physical activity phase that may be 
characterized by a slower aging rate (McBurney et al., 
2003; Chen et al., 2005a), as shown for the role of Sir2 
in the S. cerevisiae chronological life span (Fabrizio et 
al., 2005).
Sirtuins and Neurodegeneration
Both in C. elegans and mammals, specific neurological 
functions have been attributed to Sir2 orthologs (Figure 
3). To study neuronal cytotixicity in worms, Parker et al. 
developed a system in which a fragment of the human 
Huntington disease-associated protein, htt, is expressed 
in touch receptor neurons (Parker et al., 2005). Either 
increased dosage of sir-2.1 or exposure to resveratrol 
rescued neuronal dysfunction. The authors speculated 
that SIR-2.1-dependent activation of stress-responsive 
daf-16 targets may be promoting cell survival. Nothing to 
date has been reported that directly links Sirt1 with htt in 
mammals. However, Sirt1 does appear to inhibit axonal 
degeneration, a process that often precedes neuronal 
death in neurodegenerative diseases such as Parkin-
son’s and Alzheimer’s (Araki et al., 2004). This activity of 
Sirt1 was discovered because slow axonal degeneration 
in a strain of mutant mice was linked to overexpression 
of a NAD biosynthetic enzyme. Of note, another elegant 
study examining axonal degeneration attributed the ben-
efits of increased NAD biosynthesis to Sirt1-independ-
ent alterations in local bioenergetics (Wang et al., 2005). 
These authors pinpointed the deteriorative decline in 
NAD levels to axons and not the nucleus where Sirt1 
activity is presumably regulated. A final study related 
to neurodegeneration examined NF-κB signaling in 
microglia, an activity linked to amyloid-β neuronal death 
and Alzheimer’s disease, finding that overexpression of 
Sirt1 repressed NF-κB signaling by reducing RelA/p65 
acetylation (Chen et al., 2005b). Together, these findings 
call for increased examination of Sirt1 as a possible pro-
tective agent in neurons.
Sir2 Deacetylases: Anti-aging, Pro-aging, or Both?
In summary, the results in S. cerevisiae and inverte-
brate model systems, coupled with similarities between 
Sirt1-deficient and long-lived IGF-I-deficient dwarf mice 
(Longo and Finch, 2003), suggest that the safest bet at 
this point is that Sir2 deacetylases play both pro- and 
anti-aging roles in different contexts. One hypothesis to 
be tested is that reduced Sir2/Sirt1 activity can promote 
life-span extension by causing entry into a slow aging 
starvation response phase whereas Sir2/Sirt1 overex-
pression can promote life-span extension by inducing 
other changes such as fat breakdown and enhanced 
physical activity.
The field critically awaits studies of mouse longevity. 
Will mice overexpressing Sirt1, mice deficient in Sirt1, 
or neither enjoy extended longevity? Will CR extend life 
span in mice lacking Sirt1? Will Sirt1 deficiency further 
extend the life span of mice with mutations in the IGF-
1/Akt pathway? Other critical mechanistic questions 
also remain to be answered. What are the key targets of 
the Sirt1 deacetylase? Does resveratrol stimulate Sirtuin 
activity toward biological substrates and, if so, which 
ones? These results and others will no doubt begin to 
clarify the links between Sirtuins and mammalian lon-
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